Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of carbabenzpyride for uncomplicated influenza A
2010-018564-17Phase 2Terminated
- Sponsor
- Farmak
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carbamazepine in Influenza A infection, sponsored by Farmak. Started Oct 2010; status: terminated.
02
Drugs
carbamazepine
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2010-018564-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018564-17.